These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37124528)

  • 21. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With
    Wang Z; Wang H; Sun X; Fang Y; Lu SS; Ding SN; Chen XS; Shen KW
    Front Oncol; 2020; 10():14. PubMed ID: 32038988
    [No Abstract]   [Full Text] [Related]  

  • 22. A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study.
    Xiong Y; Shi X; Hu Q; Wu X; Long E; Bian Y
    Front Oncol; 2021; 11():600768. PubMed ID: 34150607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.
    Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka S; Bebb DG; Cheung WY
    Am J Clin Oncol; 2019 Jan; 42(1):75-81. PubMed ID: 30211724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.
    Xiao W; Zheng S; Liu P; Zou Y; Xie X; Yu P; Tang H; Xie X
    Cancer Med; 2018 Mar; 7(3):922-930. PubMed ID: 29473333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.
    Wen J; Ye F; Xie F; Liu D; Huang L; Fang C; Zhong S; Ren L
    Cancer Med; 2020 Jul; 9(13):4656-4666. PubMed ID: 32396284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database.
    Xie J; Ying YY; Xu B; Li Y; Zhang X; Li C
    Ther Adv Med Oncol; 2019; 11():1758835919889003. PubMed ID: 31798694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer.
    Wang Z; Wang H; Ding X; Chen X; Shen K
    Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Prognostic Model for Breast Cancer With Liver Metastasis.
    Ji L; Fan L; Zhu X; Gao Y; Wang Z
    Front Oncol; 2020; 10():1342. PubMed ID: 33014776
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
    Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.
    Zhao HY; Gong Y; Ye FG; Ling H; Hu X
    Cancer Manag Res; 2018; 10():5937-5950. PubMed ID: 30538544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors in Stage IV Colorectal Cancer Patients With Resection of Liver and/or Pulmonary Metastases: A Population-Based Cohort Study.
    Peng P; Luan Y; Sun P; Wang L; Zeng X; Wang Y; Cai X; Ren P; Yu Y; Liu Q; Ma H; Chang H; Song B; Fan X; Chen Y
    Front Oncol; 2022; 12():850937. PubMed ID: 35372009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
    Wong Y; Raghavendra AS; Hatzis C; Irizarry JP; Vega T; Horowitz N; Barcenas CH; Chavez-MacGregor M; Valero V; Tripathy D; Pusztai L; Murthy RK
    Oncologist; 2019 Mar; 24(3):313-318. PubMed ID: 30139836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
    de Maar JS; Luyendijk M; Suelmann BBM; van der Kruijssen DEW; Elias SG; Siesling S; van der Wall E
    Breast Cancer Res Treat; 2023 Apr; 198(2):253-264. PubMed ID: 36648694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Prognostic Factor Index Among Women With HR
    Vidal GA; Carter GC; Gilligan AM; Saverno K; Zhu YE; Price GL; DeLuca A; Smyth EN; Rybowski S; Huang YJ; Schwartzberg LS
    Clin Breast Cancer; 2021 Aug; 21(4):317-328.e7. PubMed ID: 33678566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.